Wevet Pharmaceuticals Private Limited

Wevet Pharmaceuticals Private Limited - trading in Allahabad, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U51909UP2019PTC111895 Incorporated 03 January 2019 ROC Uttar Pradesh HQ Allahabad, Uttar Pradesh, India
Active Private Limited Company trading MSME · Micro
Data last updated
Revenue · FY 2024
₹42.84 Lakh
▲ 69% YoY
Net profit · FY 2024
₹25,779
Net margin 0.6%
EBITDA · FY 2024
₹25,779
EBITDA margin 0.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Wevet Pharmaceuticals Private Limited

Data last updated:

Wevet Pharmaceuticals Private Limited is a private limited company based in Allahabad, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 03 January 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51909UP2019PTC111895. Its GSTIN is 09AACCW3451A1ZN (Uttar Pradesh).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Priyanka Shukla and Savitri.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 98F/2 Anand Nagar Naini, Allahabad, Uttar Pradesh, India – 211008.

As per the financials filed for FY 2024, the company reported a revenue of ₹42.84 Lakh, a growth of 69% compared to the previous year. For the same year it recorded a net profit of ₹25,779 (net margin 0.6%) and EBITDA of ₹25,779 (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years.

Wevet Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-03-0036370).

Company details

CIN U51909UP2019PTC111895
Registration Number 111895
Incorporation Date 03 January 2019
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-UP-03-0036370

Recognitions & Rankings of Wevet Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-UP-03-0036370

Contact details

Wevet Pharmaceuticals Private Limited's registered office is in Allahabad, Uttar Pradesh. Its e-mail address is in the company report.

  • Email
  • Registered Address
    98F/2 Anand Nagar Naini, Allahabad, Uttar Pradesh, India – 211008
  • Industry
    Trading, Specialty, Wholesale

To see the full contact details of Wevet Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Wevet Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Wevet Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Wevet Pharmaceuticals Private Limited, buy the company report.

Financials of Wevet Pharmaceuticals Private Limited

FY 2024 filings available

Wevet Pharmaceuticals Private Limited reported revenue of ₹42.84 Lakh (up 69% YoY) for FY 2024.

Revenue · FY 2024
₹42.84 Lakh ▲ 69%
Net profit · FY 2024
₹25,779 margin 0.6%
EBITDA · FY 2024
₹25,779 margin 0.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 69%
3 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▲ 173%
3 years · compounded
▼ 33%

Revenue has grown at a compounded annual rate (CAGR) of 24% over three years, including 69% growth in the latest year. EBITDA rose 173% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹25,779
Profit Before Tax
Tax Expense
Net Profit (PAT)₹25,779
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin0.6%
Net Profit Margin0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Wevet Pharmaceuticals Private Limited, buy the company report.

Board of directors of Wevet Pharmaceuticals Private Limited

Wevet Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Priyanka ShuklaDirector03 Jan 20197 Years 10 MonthsCurrent
SavitriDirector03 Jan 20197 Years 10 MonthsCurrent

Peer comparison

Wevet Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
SMV Pharmaceuticals Private Limited₹42.95 Lakh (FY 2025)2.0%Chandigarh, India
Arlics Pharmaceuticals Private Limited₹42.92 Lakh (FY 2025)1.0%Mehsana, Gujarat, India
Torrey Pharmaceuticals Private Limited₹42.92 Lakh (FY 2024)116.0%Nagpur, Maharashtra, India
Denexo Pharmaceuticals Private Limited₹42.9 Lakh (FY 2025)4.0%Kharghar, Maharashtra, India
Trumedis Pharmaceuticals Private Limited₹42.85 Lakh (FY 2025)0.0%New Delhi, Delhi, India
Wevet Pharmaceuticals Private Limitedthis company₹42.84 Lakh (FY 2024)₹25,7790.6%69.0%Allahabad, Uttar Pradesh, India

To see the full peer comparison of Wevet Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Wevet Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Wevet Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AACCW3451A1ZNUttar PradeshActive28 Jun 2019

To see the full GST registrations and return filing status of Wevet Pharmaceuticals Private Limited, buy the company report.

Recent activity

Wevet Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Priyanka Shukla was appointed as Director on 03 Jan 2019.

AGM
Wevet Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Wevet Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttar Pradesh I.
Appointed
Priyanka Shukla was appointed as Director.
Appointed
Savitri was appointed as Director.
Incorporation
03 Jan 2019
Wevet Pharmaceuticals Private Limited was registered on 03 Jan 2019 with Roc Uttar Pradesh I & aged 7 years 10 months as per MCA records.

Frequently asked questions

Wevet Pharmaceuticals is an active private limited company based in Allahabad, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 03 January 2019 (7+ years old) and is registered under CIN U51909UP2019PTC111895.

Wevet Pharmaceuticals has 2 current directors:

The latest financial statements of Wevet Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Wevet Pharmaceuticals is 09AACCW3451A1ZN, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Wevet Pharmaceuticals is U51909UP2019PTC111895. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Wevet Pharmaceuticals was incorporated on 03 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.

The peers of Wevet Pharmaceuticals by revenue are SMV Pharmaceuticals Private Limited, Arlics Pharmaceuticals Private Limited, Torrey Pharmaceuticals Private Limited, Denexo Pharmaceuticals Private Limited, Trumedis Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Priyanka Shukla was appointed as Director on 03 Jan 2019. Savitri was appointed as Director on 03 Jan 2019.

Yes, Wevet Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-03-0036370).

The registered office of Wevet Pharmaceuticals is at 98F2 Anand Nagar Naini, Allahabad, Uttar Pradesh, India – 211008.

Wevet Pharmaceuticals operates in the trading industry, in the specialty segment.